EXPRESS VONCERT PHOENIX - BAYER/MODERNA/ROCHE GS Stock

Certificat

F33714

DE000VU2XKM0

Market Closed - Borsa Italiana 11:44:59 2024-06-14 am EDT
73.45 EUR -3.80% Intraday chart for EXPRESS VONCERT PHOENIX - BAYER/MODERNA/ROCHE GS
Current month-14.14%
1 month-12.92%
Date Price Change
24-06-14 73.45 -3.80%
24-06-13 76.35 -3.42%
24-06-12 79.05 +1.02%
24-06-11 78.25 -1.76%
24-06-10 79.65 -3.63%

Real-time Borsa Italiana

Last update June 14, 2024 at 11:44 am EDT

More quotes

Static data

Product typeOther Certificates
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
F33714
ISINDE000VU2XKM0
Date issued 2023-02-02
Maturity 2028-02-02 (1326 Days)
Parity 1 : 1
Emission price 100
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 100
Lowest since issue 61.35
Spread 1.8
Spread %2.42%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
247.6 CHF
Average target price
278.1 CHF
Spread / Average Target
+12.30%
Consensus
  1. Stock Market
  2. Certificates
  3. F33714 Certificat